Expertise in
4
conditions

Christoph Laske

Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 
Expertise in
4
conditions
Hoppe Seyler Str. 3, 
Tuebingen, BW, DE 

Overview

Christoph Laske practices practicing medicine in Tuebingen, Germany.

Mr. Laske is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Alzheimer's Disease, Dementia, Developmental Dysphasia Familial, and Memory Loss.

He is actively involved in clinical research, co-authoring 189 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Hoppe Seyler Str. 3, Tuebingen, BW 72076, Germany
Other Locations
Calwer Street 14, 72076, Germany
Calwer Str. 14, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype
Enrollment Status: Completed
Publish Date: November 10, 2025
Intervention Type: Drug
Study Drug: ALZ-801
Study Phase: Phase 3
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
Enrollment Status: Terminated
Publish Date: December 03, 2019
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

189 Total Publications

Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-AD.
Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-AD.
Journal: medRxiv : the preprint server for health sciences
Published: July 10, 2026

Frequently Asked Questions about Christoph Laske

Is Christoph Laske a top-rated expert for Alzheimer's Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Christoph Laske is classified as an Elite expert for Alzheimer's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Christoph Laske participate in research or clinical trials?

Yes. Christoph Laske has published 189 articles and abstracts on conditions like Alzheimer's Disease. You can view a list of Christoph Laske's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Laske's expertise for a condition
ConditionClose
View All 7 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile